Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAA Supplementation for Atrophy Prevention in TKA
NCT02145949Phase 2Completed
- Sponsor
- University of Oregon
- Start
- Dec 2014
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by University of Oregon. Primary endpoints: MRI Quadriceps Involved Leg at 6 weeks, MRI Quadriceps Contralateral Leg at 6 weeks and 2 more. Started Dec 2014; status: completed.
Beyond the preview
Go deeper on NCT02145949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145949.